ABEO

Abeona Therapeutics · USD

Market open US (NYSE / Nasdaq) · 09:30–16:00 · Mon 14:15 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About Abeona Therapeutics

Abeona Therapeutics (ABEO) is a biopharmaceutical company focused on developing treatments for rare genetic diseases, though specific details about its core business, main products, or services are not widely publicized. If I were to guess based on the sector it operates in, it would be in pharmaceuticals and biotechnology.

Ticker	ABEO
Name	Abeona Therapeutics
Currency	USD

Reputation

😎

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

…

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BEARISH

46.03

RSI (14)i

5.53

SMA 20i

5.44

SMA 50i

5.27

SMA 200i

-0.28%

1di

-6.79%

1wi

-4.49%

1mi

3.04%

30d voli

7.23

52w highi

4.17

52w lowi

-24.97%

from highi

0.01

MACDi

Uptrend (50d above 200d)MACD bearish crossover

Computed from 255 locally-stored price bars.

AI signals

HOLD 70% · long_term 2026-06-07 23:32

The stock has been in a consolidation phase with minor fluctuations around the current level of 5.46 USD. There are no recent news or significant market events to support either a strong bull or bear case, thus maintaining a cautious stance.

qwen2.5:3b